Verified 99.81% HPLC
IN STOCK, FAST SHIPPING
RESEARCH-USE-ONLY CATALOG ITEM
CJC-1295 with DAC 5 mg
Long-acting growth-hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex (DAC) extension, studied in laboratory endocrine research models.
£58.99
About CJC-1295 with DAC 5 mg
CJC-1295 with DAC is a modified GHRH analog featuring a Drug Affinity Complex (DAC) that extends its half-life relative to unmodified GHRH fragments, studied in laboratory research on sustained growth-hormone secretagogue receptor signaling. Each batch is HPLC and mass-spec verified before release.
At a glance
- • Product: CJC-1295 with DAC 5 mg
- • Catalog information: Catalog specification published
- • Form: Sealed vial
- • Storage: Store at -20C. Protect from light.
- • Shipping: Ships from within the UK; most orders arrive in under 7 days after processing.
Quality & Laboratory Guidelines
Every batch of CJC-1295 with DAC undergoes rigorous dual HPLC and ESI-Mass Spectrometry analysis to guarantee >99.81% purity identity. Vials are vacuum-sealed under nitrogen atmosphere for optimal long-term shelf stability.
Important Notice
- • Compliance: Strictly for in-vitro research and laboratory testing only.
- • Restrictions: Not for human or animal consumption, medical treatment, or diagnostic use.
- • Verification: Batch purity certificates available upon request using your vial lot number.
Frequently Asked Questions
Yes. Every batch of CJC-1295 with DAC 5 mg is verified via HPLC and mass spectrometry before release, with a Certificate of Analysis available by lot number through our COA lookup tool.
The 10-vial kit option offers a 30% discount compared with purchasing 10 individual vials, intended for laboratories running extended or comparative research protocols.
Store the lyophilized vial at -20C, protected from light. Orders ship from our UK Glasgow hub in appropriate packaging, with most arriving within 7 days after processing.